Cspc Pharmaceutical | 1093 - Vertriebs- Und Verwaltungskosten

Aktienkurs
8.98
Täglich Wechseln
0.06 0.67%
Monatlich
5.77%
Jährlich
46.97%
Q2 Prognose
8.80




Vertriebs- Und Verwaltungskosten Veränderung Datum
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 585K 84K 2025-09
Avita Medical AUD 19.03M 1.95M 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
Jiangsu Hengrui CNY 2.81B 191.05M 2026-03
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Moderna USD 308M 40M 2025-12
Organon & Co USD 399M 54M 2025-09
Revvity USD 251.73M 9.82M 2025-12
Sh Fosun Pharma CNY 4.44B 1.32B 2025-12
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tectonic Therapeutic USD 3.44M 1.52M 2025-12
Viatris USD 1.03B 144.1M 2025-12
Wuxi Apptec CNY 1.04B 261.09M 2025-12
Xeris Pharmaceuticals USD 42.64M 3.82M 2025-12
Zz Pientze Pharmaceu CNY 171.91M 343.2M 2025-09